102
Participants
Start Date
July 16, 2024
Primary Completion Date
June 30, 2025
Study Completion Date
June 30, 2025
PD-1 monoclonal antibody consolidation therapy
PD-1 monoclonal antibody-based consolidation therapy for 1 year after completion of radiotherapy (or combination chemotherapy up to 4 cycles if less than 4 cycles of chemotherapy). Specific dosing: PD-1 monoclonal antibody, 200mg every 3 weeks.
RECRUITING
Cancer hospital, CAMS, Beijing
Peking University Cancer Hospital & Institute
OTHER
Hebei Medical University Fourth Hospital
OTHER
Tianjin Medical University Cancer Institute and Hospital
OTHER
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
OTHER